Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation

Imiquimod (IMQ), a nucleoside analogue of the imidazoquinoline family, is used in the topical treatment of basal cell carcinoma (BCC) and other skin diseases. It is reported to be a TLR7 and TLR8 agonist and, as such, initiates a Th1 immune response by activating sentinel cells in the vicinity of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolff, F, Loipetzberger, A, Gruber, W, Esterbauer, H, Aberger, F, Frischauf, A M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898320/
https://www.ncbi.nlm.nih.gov/pubmed/23995793
http://dx.doi.org/10.1038/onc.2013.343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898320/
https://www.ncbi.nlm.nih.gov/pubmed/23995793
http://dx.doi.org/10.1038/onc.2013.343

Ejemplares similares